Company page
Sprint Bioscience Ab
Sprint Bioscience AB is a public company listed on the Swedish market under the ticker SPRINT. The company has a market capitalization of approximately 41 million SEK. Sprint Bioscience focuses on developing innovative therapies for cancer treatment.
- Ticker
- SPRINT
- Market cap
- $41.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major